Scolding N J, Morgan B P, Campbell A K, Compston D A
Section of Neurology, University of Cambridge Clinical School, Addenbrooke's Hospital, U.K.
J Neurol Sci. 1990 Jul;97(2-3):155-62. doi: 10.1016/0022-510x(90)90214-8.
Rat oligodendrocytes are known to be susceptible to complement attack when exposed to homologous serum as a consequence of anti-myelin antibody independent classical pathway complement activation and attack. We have now compared this susceptibility with that of other cells of the oligodendrocyte-type 2 astrocyte (O-2A) lineage, and show that while type 2 astrocytes are not sensitive, O-2A progenitors are only relatively resistant to serum cytotoxicity, higher concentrations of complement resulting in cell damage. The implications of these findings for the pathogenesis of demyelinating disease are discussed.